Download presentation
Presentation is loading. Please wait.
Published byCuthbert Holland Modified over 8 years ago
1
Class Five Part 2
2
Alterations of Musculoskeletal Function Chapter 37
3
Osteoporosis Porous bone Porous bone Poorly mineralized bone Poorly mineralized bone Bone density Bone density Normal bone Normal bone 833 mg/cm 2 833 mg/cm 2 Osteopenic bone Osteopenic bone 833 to 648 mg/cm 2 833 to 648 mg/cm 2 Osteoporosis Osteoporosis <648 mg/cm 2 <648 mg/cm 2
4
Osteoporosis Potential causes Potential causes Decreased levels of estrogen and testosterone Decreased levels of estrogen and testosterone Decreased activity level Decreased activity level Inadequate levels of vitamins D and C, or Mg ++ Inadequate levels of vitamins D and C, or Mg ++
5
Osteoporosis Demonstrated by reduced bone mass/density and an imbalance of bone resorption and formation Demonstrated by reduced bone mass/density and an imbalance of bone resorption and formation Bone histology is usually normal but it lacks structural integrity Bone histology is usually normal but it lacks structural integrity
6
Osteoporosis
7
Osteoporosis
8
Osteoporosis Iatrogenic osteoporosis Iatrogenic osteoporosis Regional osteoporosis Regional osteoporosis Postmenopausal osteoporosis Postmenopausal osteoporosis Glucocorticoid-induced osteoporosis Glucocorticoid-induced osteoporosis Age-related bone loss Age-related bone loss
9
Osteoporosis
10
Osteoporosis
11
Osteoporosis
12
Osteomalacia Deficiency of vitamin D lowers the absorption of calcium from the intestines Deficiency of vitamin D lowers the absorption of calcium from the intestines Inadequate or delayed mineralization Inadequate or delayed mineralization Bone formation progresses to osteoid formation but calcification does not occur; the result is soft bones Bone formation progresses to osteoid formation but calcification does not occur; the result is soft bones Pain, bone fractures, vertebral collapse, bone malformation Pain, bone fractures, vertebral collapse, bone malformation
13
Osteomyelitis Osteomyelitis is most often caused by a staphylococcal infection Osteomyelitis is most often caused by a staphylococcal infection Most common cause is open wound (exogenous); also can be from a blood-borne (endogenous) infection Most common cause is open wound (exogenous); also can be from a blood-borne (endogenous) infection
14
Osteomyelitis Manifestations Manifestations Acute and chronic inflammation, fever, pain, necrotic bone Acute and chronic inflammation, fever, pain, necrotic bone Treatment Treatment Antibiotics, débridement, surgery, hyperbaric oxygen therapy Antibiotics, débridement, surgery, hyperbaric oxygen therapy
15
Osteomyelitis
16
Osteomyelitis
17
Inflammatory vs. Noninflammatory Joint Disease Differentiated by: Differentiated by: Absence of synovial membrane inflammation Absence of synovial membrane inflammation Lack of systemic signs and symptoms Lack of systemic signs and symptoms Normal synovial fluid analysis Normal synovial fluid analysis
18
Inflammatory Joint Disease Commonly called osteoarthritis Commonly called osteoarthritis Characterized by inflammatory damage or destruction in the synovial membrane or articular cartilage and by systemic signs of inflammation Characterized by inflammatory damage or destruction in the synovial membrane or articular cartilage and by systemic signs of inflammation Fever, leukocytosis, malaise, anorexia, and hyperfibrinogenemia Fever, leukocytosis, malaise, anorexia, and hyperfibrinogenemia Infectious or noninfectious Infectious or noninfectious
19
Osteoarthritis Degeneration and loss of articular cartilage, sclerosis of bone underneath cartilage, and formation of bone spurs (osteophytes) Degeneration and loss of articular cartilage, sclerosis of bone underneath cartilage, and formation of bone spurs (osteophytes) Also referred to as degenerative joint disease Also referred to as degenerative joint disease Incidence increases with age Incidence increases with age Primary disease is idiopathic Primary disease is idiopathic
20
Osteoarthritis Osteoarthritis is characterized by local areas of damage and loss of articular cartilage, new bone formation of joint margins, subchondral bone changes, and variable degrees of mild synovitis and thickening of the joint capsule Osteoarthritis is characterized by local areas of damage and loss of articular cartilage, new bone formation of joint margins, subchondral bone changes, and variable degrees of mild synovitis and thickening of the joint capsule Manifestations Manifestations Pain, stiffness, enlargement of the joint, tenderness, limited motion, and deformity Pain, stiffness, enlargement of the joint, tenderness, limited motion, and deformity
21
Osteoarthritis
22
Osteoarthritis
23
Osteoarthritis
24
Osteoarthritis
25
Rheumatoid Arthritis Inflammatory joint disease Inflammatory joint disease Systemic autoimmune damage to connective tissue, primarily in the joints (synovial membrane) Systemic autoimmune damage to connective tissue, primarily in the joints (synovial membrane) Similar symptoms to osteoarthritis Similar symptoms to osteoarthritis
26
Rheumatoid Arthritis Presence of rheumatoid factors (RA or RF test) Presence of rheumatoid factors (RA or RF test) Antibodies (IgG and IgM) against antibodies Antibodies (IgG and IgM) against antibodies Joint fluid presents with inflammatory exudate Joint fluid presents with inflammatory exudate
27
Rheumatoid Arthritis Pathogenesis Pathogenesis CD4 T helper cells and other cells in the synovial fluid become activated and release cytokines CD4 T helper cells and other cells in the synovial fluid become activated and release cytokines Recruitment and retention of inflammatory cells in the joint sublining region Recruitment and retention of inflammatory cells in the joint sublining region Cycle of altered cytokine and signal transduction pathways Cycle of altered cytokine and signal transduction pathways
28
Rheumatoid Arthritis Pathogenesis Pathogenesis Possible immune complex deposition and inflammatory cytokine release Possible immune complex deposition and inflammatory cytokine release RANKL release and osteoclast activation RANKL release and osteoclast activation Angiogenesis in the synovium Angiogenesis in the synovium
29
Rheumatoid Arthritis Evaluation Evaluation Four or more of the following: Four or more of the following: Morning joint stiffness lasting at least 1 hour Morning joint stiffness lasting at least 1 hour Arthritis of three or more joint areas Arthritis of three or more joint areas Arthritis of the hand joints Arthritis of the hand joints Symmetric arthritis Symmetric arthritis Rheumatoid nodules Rheumatoid nodules Abnormal amounts of serum rheumatoid factor Abnormal amounts of serum rheumatoid factor Radiographic changes Radiographic changes
30
Rheumatoid Arthritis
33
Structure, Function, and Disorders of the Integument Chapter 39
34
Layers of the Skin Epidermis Epidermis Dermis Dermis Hypodermis Hypodermis
35
Layers of the Skin
36
Dermal appendages Dermal appendages Nails Nails Hair Hair Sebaceous glands Sebaceous glands Eccrine and apocrine sweat glands Eccrine and apocrine sweat glands Blood supply Blood supply Papillary capillaries Papillary capillaries
37
Clinical Manifestations of Skin Dysfunction Macule Macule Papule Papule Patch Patch Plaque Plaque Wheal Wheal Nodule Nodule Tumor Tumor Vesicle Vesicle Bulla Bulla Pustule Pustule Cyst Cyst Telangiectasia Telangiectasia Scale Scale Lichenification Lichenification Keloid Keloid Scar Scar Excoriation Excoriation Fissure Fissure Erosion Erosion Ulcer Ulcer Atrophy Atrophy
38
Pressure Ulcers Pressure ulcers result from any unrelieved pressure on the skin, causing underlying tissue damage Pressure ulcers result from any unrelieved pressure on the skin, causing underlying tissue damage Pressure Pressure Shearing forces Shearing forces Friction Friction Moisture Moisture
39
Pressure Ulcers
40
Stages Stages Nonblanchable erythema of intact skin Nonblanchable erythema of intact skin Partial-thickness skin loss involving epidermis or dermis Partial-thickness skin loss involving epidermis or dermis Full-thickness skin loss involving damage or loss of subcutaneous tissue Full-thickness skin loss involving damage or loss of subcutaneous tissue Full-thickness skin loss with damage to muscle, bone, or supporting structures Full-thickness skin loss with damage to muscle, bone, or supporting structures
41
Keloids Elevated, rounded, and firm Elevated, rounded, and firm Clawlike margins that extend beyond the original site of injury Clawlike margins that extend beyond the original site of injury Excessive collagen formation during dermal connective tissue repair Excessive collagen formation during dermal connective tissue repair Common in darkly pigmented skin types and burn scars Common in darkly pigmented skin types and burn scars Type III collagen is increased Type III collagen is increased
42
Keloids
43
Pruritus Itching Itching Most common symptom of primary skin disorders Most common symptom of primary skin disorders Itch is carried by specific unmyelinated C-nerve fibers and is triggered by a number of itch mediators Itch is carried by specific unmyelinated C-nerve fibers and is triggered by a number of itch mediators The CNS can modulate the itch response The CNS can modulate the itch response
44
Pruritus Pain stimuli at lower intensities can induce itching Pain stimuli at lower intensities can induce itching Chronic itching can result in infections and scarring due to persistent scratching Chronic itching can result in infections and scarring due to persistent scratching
45
Inflammatory Disorders Allergic contact dermatitis Allergic contact dermatitis Caused by a hypersensitivity type IV reaction Caused by a hypersensitivity type IV reaction The allergen comes in contact with the skin, binds to a carrier protein to form a sensitizing antigen; Langerhans cells process the antigen and carry it to T cells, which become sensitized to the antigen The allergen comes in contact with the skin, binds to a carrier protein to form a sensitizing antigen; Langerhans cells process the antigen and carry it to T cells, which become sensitized to the antigen Manifestations: erythema, swelling, pruritus, vesicular lesions Manifestations: erythema, swelling, pruritus, vesicular lesions
46
Allergic Contact Dermatitis
47
Inflammatory Disorders Atopic dermatitis Atopic dermatitis Type I hypersensitivity—activation of mast cells, eosinophils, T-lymphocytes, and other inflammatory cells Type I hypersensitivity—activation of mast cells, eosinophils, T-lymphocytes, and other inflammatory cells Causes red, weeping crusts and chronic inflammation, lichenification Causes red, weeping crusts and chronic inflammation, lichenification
48
Inflammatory Disorders Irritant contact dermatitis Irritant contact dermatitis Nonimmunologic inflammation of the skin Nonimmunologic inflammation of the skin Chemical irritation from acids or prolonged exposure to irritating substances Chemical irritation from acids or prolonged exposure to irritating substances Symptoms similar to allergic contact dermatitis Symptoms similar to allergic contact dermatitis Treatment—remove stimulus Treatment—remove stimulus
49
Inflammatory Disorders Stasis dermatitis Stasis dermatitis Occurs in the legs as a result of venous stasis, edema, and vascular trauma Occurs in the legs as a result of venous stasis, edema, and vascular trauma Sequence of events: erythema, pruritus, scaling, petechiae, ulcerations Sequence of events: erythema, pruritus, scaling, petechiae, ulcerations
50
Inflammatory Disorders Seborrheic dermatitis Seborrheic dermatitis Inflammation of the skin involving the scalp, eyebrows, eyelids, nasolabial folds, and ear canals Inflammation of the skin involving the scalp, eyebrows, eyelids, nasolabial folds, and ear canals Scaly, white, or yellowish plaques Scaly, white, or yellowish plaques
51
Stasis and Seborrheic Dermatitis
52
Papulosquamous Disorders Psoriasis Psoriasis Chronic, relapsing, proliferative skin disorder Chronic, relapsing, proliferative skin disorder T cell immune–mediated skin disease T cell immune–mediated skin disease Scaly, thick, silvery, elevated lesions, usually on the scalp, elbows, or knees caused by a high rate of mitosis in the basale layer Scaly, thick, silvery, elevated lesions, usually on the scalp, elbows, or knees caused by a high rate of mitosis in the basale layer
53
Papulosquamous Disorders Psoriasis Psoriasis Shows evidence of dermal and epidermal thickening Shows evidence of dermal and epidermal thickening Epidermal turnover goes from 26 to 30 days to 3 to 4 days Epidermal turnover goes from 26 to 30 days to 3 to 4 days Cells do not have time to mature or adequately keratinize Cells do not have time to mature or adequately keratinize
54
Psoriasis
55
Papulosquamous Disorders Pityriasis rosea Pityriasis rosea Benign, self-limiting inflammatory disorder Benign, self-limiting inflammatory disorder Usually occurs during the winter months Usually occurs during the winter months Herald patch Herald patch Circular, demarcated, salmon-pink, 3- to 4-cm lesion Circular, demarcated, salmon-pink, 3- to 4-cm lesion
56
Papulosquamous Disorders
57
Lichen planus Lichen planus Benign, inflammatory disorder of the skin and mucous membranes Benign, inflammatory disorder of the skin and mucous membranes Unknown origin, but T cells, adhesion molecules, inflammatory cytokines, and antigen presenting cells are involved Unknown origin, but T cells, adhesion molecules, inflammatory cytokines, and antigen presenting cells are involved Nonscaling, violet-colored, 2- to 4-mm lesions Nonscaling, violet-colored, 2- to 4-mm lesions Wrists, ankles, lower legs, genitalia Wrists, ankles, lower legs, genitalia
58
Lichen Planus
59
Papulosquamous Disorders Acne vulgaris Acne vulgaris Inflammatory disease of the pilosebaceous follicles Inflammatory disease of the pilosebaceous follicles
60
Papulosquamous Disorders Acne rosacea Acne rosacea Inflammation of the skin that develops in adulthood Inflammation of the skin that develops in adulthood Lesions Lesions Erythematotelangiectatic, papulopustular, phymatous, and ocular Erythematotelangiectatic, papulopustular, phymatous, and ocular Associated with chronic, inappropriate vasodilation resulting in flushing and sensitivity to the sun Associated with chronic, inappropriate vasodilation resulting in flushing and sensitivity to the sun
61
Papulosquamous Disorders Lupus erythematosus Lupus erythematosus Inflammatory, autoimmune disease with cutaneous manifestations Inflammatory, autoimmune disease with cutaneous manifestations Discoid lupus erythematosus Discoid lupus erythematosus Restricted to the skin Restricted to the skin Photosensitivity Photosensitivity Butterfly pattern over the nose and cheeks Butterfly pattern over the nose and cheeks Systemic lupus erythematosus Systemic lupus erythematosus
62
Vesiculobullous Disorders Pemphigus Pemphigus Rare, chronic, blister-forming disease of the skin and oral mucous membranes Rare, chronic, blister-forming disease of the skin and oral mucous membranes Blisters form in the deep or superficial epidermis Blisters form in the deep or superficial epidermis Autoimmune disease caused by circulating IgG autoantibodies Autoimmune disease caused by circulating IgG autoantibodies The antibodies are against the cell surface adhesion molecule, desmoglein in the suprabasal layer of the epidermis The antibodies are against the cell surface adhesion molecule, desmoglein in the suprabasal layer of the epidermis
63
Vesiculobullous Disorders Pemphigus Pemphigus Tissue biopsies demonstrate autoantibody presence Tissue biopsies demonstrate autoantibody presence Types Types Pemphigus vulgaris (severe) Pemphigus vulgaris (severe) Pemphigus foliaceus Pemphigus foliaceus Pemphigus erythematosus Pemphigus erythematosus
64
Vesiculobullous Disorders Bullous pemphigoid Bullous pemphigoid More benign disease than pemphigus vulgaris More benign disease than pemphigus vulgaris Bound IgG and blistering of the subepidermal skin layer Bound IgG and blistering of the subepidermal skin layer Subepidermal blistering and eosinophils distinguish pemphigoid from pemphigus Subepidermal blistering and eosinophils distinguish pemphigoid from pemphigus
65
Bullous Pemphigoid
66
Vesiculobullous Disorders Erythema multiforme Erythema multiforme Acute, recurring disorder of the skin and mucous membranes Acute, recurring disorder of the skin and mucous membranes Associated with allergic or toxic reactions to drugs or microorganisms Associated with allergic or toxic reactions to drugs or microorganisms Caused by immune complexes formed and deposited around dermal blood vessels, basement membranes, and keratinocytes Caused by immune complexes formed and deposited around dermal blood vessels, basement membranes, and keratinocytes
67
Vesiculobullous Disorders Erythema multiforme Erythema multiforme “Bull’s-eye” or target lesion “Bull’s-eye” or target lesion Erythematous regions surrounded by rings of alternating edema and inflammation Erythematous regions surrounded by rings of alternating edema and inflammation
68
Vesiculobullous Disorders Erythema multiforme Erythema multiforme Bullous lesions form erosions and crusts when they rupture Bullous lesions form erosions and crusts when they rupture Affects the mouth, air passages, esophagus, urethra, and conjunctiva Affects the mouth, air passages, esophagus, urethra, and conjunctiva Severe forms Severe forms Stevens-Johnson syndrome (bullous form) Stevens-Johnson syndrome (bullous form) Toxic epidermal necrolysis Toxic epidermal necrolysis
69
Infections Bacterial infections Bacterial infections Folliculitis Folliculitis Furuncles Furuncles Carbuncles Carbuncles Cellulitis Cellulitis Erysipelas Erysipelas Impetigo Impetigo
70
Furuncle
71
Infections Viral infections Viral infections Herpes zoster and varicella Herpes zoster and varicella
72
Herpes Simplex Virus
73
Disorders of the Nail Paronychia Paronychia Acute or chronic infection of the cuticle Acute or chronic infection of the cuticle Onychomycosis Onychomycosis Fungal or dermatophyte infection of the nail plate Fungal or dermatophyte infection of the nail plate
74
Benign Tumors Seborrheic keratosis Seborrheic keratosis Keratoacanthoma Keratoacanthoma Actinic keratosis Actinic keratosis Nevi (moles) Nevi (moles)
75
Benign Tumors
76
Cancer Basal cell carcinoma Basal cell carcinoma Squamous cell carcinoma Squamous cell carcinoma Malignant melanoma Malignant melanoma Kaposi sarcoma Kaposi sarcoma
77
Cancer
78
Cancer
79
Cancer
80
Cancer
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.